Showing posts with label Creatinine Test Market share. Show all posts
Showing posts with label Creatinine Test Market share. Show all posts

Tuesday 29 September 2020

Creatinine Test Market Share- Research Report, Analysis by Top Companies, Key Trends and Forecast

 

Market Highlights

Creatinine test is a part of renal function tests that determine the normal functioning of kidney. It is usually recommended by the healthcare provider for diagnosis of kidney diseases, kidney failure, and other diseases associated with the kidney. Analyzer, creatinine tests strips, cartridge, and other accessories are most widely used to determine creatinine levels signaling the presence of kidney disease.

Prevalence of chronic kidney disease is on the rise across the globe, especially, in the developing countries.  The market is driven by the increasing prevalence of diabetes, renal dysfunction, and other kidney problems. Furthermore, increasing research and development activities, and technological advancements to identify the causes and risk factors for renal diseases are fuelling the global market growth.  The growth of the market is restricted by the accuracy and reliability of tests.

The global creatinine test market is expected to grow at a CAGR of 4.2% during the forecast period.

Some of the key players in the global market are Quest Diagnostics (U.S.), Merck (U.S.), Sonic Healthcare (Australia), Bayer (U.S.), Beckman Coulter (U.S.), Laboratory Corporation of America Holdings (U.S.), Genoptix (U.S.), Healthscope (Australia), Labco (Kuwait), Charles River (U.S.), OPKO Health, Inc. (U.S.), Abbott (U.S.), and others.

Taste the market data and market information presented through more than 55 market data tables and figures spread over 101 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Creatinine test market research report–Global forecast till 2023.”

Major Players in Creatinine test Market:

Regional Analysis

The creatinine test market share is increasing in the Americas owing to growing emphasis on healthy lifestyle, and prevention of chronic kidney diseases. Additionally, increasing demand for technologically advanced diagnostic devices and the presence of major market players influence the growth of the market. According to the Centre for Disease Control and Prevention, in 2014, nearly 118,000 people in the U.S. started treatment for End-Stage Renal Disease (ESRD).

In Europe, extensive research and development activities on the medical devices, and extensive use of point-care-testing devices drive the market growth. As per the article published in Clinical Kidney Journal, the incidence of end-stage renal disease (ESRD) varies substantially between the countries in Europe. Furthermore, rising healthcare expenditure also impact the market growth. According to the Organization for Economic Co-operation and Development (OECD), the healthcare expenditure in Germany was EUR 321 billion in 2014, France recorded the second highest level of current healthcare expenditure of EUR 237 billion, followed by the U.K (EUR 223 billion).

Owing to the increasing prevalence of diabetes, chronic kidney disease, and obesity, and availability of diagnostic services drives the growth of the Asia Pacific region. India and China are the top two countries with high prevalence of diabetes, which is expected to grow in the coming future.

In the Middle East & Africa, the increasing demand for specialty diagnostic services and developing healthcare system drive the growth of the market. In Africa, the demand for diagnosis and treatment of chronic diseases is increasing, which is fuelling the market growth.

Segmentation

The global creatinine tests market is segmented on the basis of type, indication, devices, and end user.

On the basis of the type, the market is segmented into urine test, blood test, and others.

On the basis of the devices & accessories, the market is segmented into clinical analyzer including bench top, and portable/ handheld analyzers, creatinine test strips, cartridge, and others.

On the basis of the indication, the market is segmented into kidney disease, kidney infection, kidney failure, urinary tract obstruction, and others.

On the basis of the end user, the market is segmented into hospital & clinics, diagnostic center, research institutes, and others.

Access Complete Report @ https://www.marketresearchfuture.com/reports/creatinine-test-market-4878

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 

Thursday 28 May 2020

Creatinine Test Market share 2019 is Expected to Surge with 5.80% CAGR by 2023, Covering Major Applications, Product types, Key players, Focused Regions, Forecasting

Creatinine Test Market Insights 
Market Research Future has assessed that the growth of the global creatinine test market is expected to register at a CAGR of 5.8% during the assessment period of 2018 to 2023. This moderate yet steady rate of growth is expected to yield a market value of USD 604.55 Mn by the end of 2023. Creatinine tests are a range of tests that are performed to ascertain creatinine levels in the blood. Creatinine itself is a waste product from the breakdown of creatine which is consistently found in the body as a part of normal function. High levels indicate kidney failure. 
The high prevalence of chronic kidney diseases due to poor urban lifestyles is expected to drive the global creatinine test market. Moreover, market players are actively advancing existing technology for kidney function testing. As a result, creatinine tests are increasingly accurate, thus driving the market. The alarming increase in kidney diseases has prompted government bodies to take initiatives in encouraging creatinine tests so as to control the growth of chronic kidney diseases. The rising approval from the FDA for creatinine tests is expected to drive the market toward new opportunities for growth. Meanwhile, the false estimates that creatinine testing sometimes provides is expected to hinder market growth over the forecasted period.
Market Segmentation
The global creatinine test market has been segmented based on test type, product type, application, and end use. By test type, the global creatinine test market has been segmented into urine test, creatinine clearance test, and blood test. The blood test segment is expected to exhibit high growth over the forecast period due to the growing preference for blood tests to measure creatinine levels over other tests. The segment was valued at USD 211.83 Mn in 2016 and is expected to expand at a CAGR of 5.32% over the forecast period. The urine test segment is expected to exhibit significant growth over the forecast period on account of advances in urine test strips which facilitate accurate diagnosis of kidney disorders. 
By product type, the global creatinine test market has been segmented into consumables and instruments. The consumables segment is the largest segment while the instruments segment is expected to be the fastest growing segment over the forecast period. The instruments segment is expected to exhibit a CAGR of 6% over the forecast period. 
By application, the global creatinine test market has been segmented into kidney cancer, renal failure, glomerulonephritis, urinary tract obstruction, and others. The urinary tract obstruction segment is anticipated to expand at a CAGR of 5.10% over the forecast period. 
By end-use, the global creatinine test market has been segmented into research institutes, diagnostic centers, hospitals and clinics, and others. The diagnostic center's segment is expected to exhibit a CAGR of 6.34% over the forecast period.
Regional Analysis
Regions in the global creatinine market have been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA). 
The Americas account for the lion's share of the global creatinine test market. A strong presence of healthcare industry leaders, extended healthcare budget, improving reimbursement scenario and surging prevalence of kidney disorders in the region favors the growth of the market. 
Europe market is expected to register a CAGR of 6.12% over the forecast period. Change in healthcare policies, the presence of sophisticated healthcare infrastructure, and rapid adoption of advanced diagnostic methods spur the growth of the Europe market. APAC is another significant market for creatinine test. APAC and Europe collectively account for 51% share of the global market. The APAC creatinine test market is catalyzed by a large patient pool, brisk adoption of the latest diagnostic methods, and improving healthcare infrastructure in the region.
Key Players
The remarkable players in the global creatinine test market include URIT Medical, Thermo Fisher Scientific, Inc., OPTI Medical Systems, Siemens AG, Abbott, Abcam plc, ARKRAY, Inc., F. Hoffmann-La Roche AG, ACON Laboratories, Inc., Quest Diagnostics, Nova Biomedical, The Danaher Corporation, and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market p3layers for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.